JANET METTS: Open Payments
NPI 1366082901 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,032 in 51 payments from 24 companies in 2025. Trend: 2023 $578 · 2024 $641 · 2025 $1,032
Food & beverage: $1,032
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $172 |
| Lilly USA, LLC | 10 | $134 |
| Novo Nordisk Inc | 4 | $85 |
| Teva Pharmaceuticals USA, Inc. | 3 | $77 |
| Abbott Laboratories | 4 | $65 |
| Mallinckrodt Hospital Products Inc. | 2 | $47 |
| PFIZER INC. | 2 | $47 |
| Astellas Pharma US Inc | 2 | $47 |
| Veloxis Pharmaceuticals, Inc. | 1 | $36 |
| SANOFI-AVENTIS U.S. LLC | 2 | $32 |
Products named: FARXIGA, JARDIANCE, AJOVY, FREESTYLE LIBRE 3, ACTHAR, Veozah, Ozempic, MOUNJARO.
Industry payments across TX — which companies pay providers there.
